MonoSol Rx’s complained that BDSI, MEDA, and Aveva’s manufacture, marketing, and sale of the Onsolis film products infringe MonoSol Rx’s US patent no 7,824,588 related to methods of making drug-containing films.
MonoSol Rx has filed its patent infringement claim against these defendants initially in November, 2010.
The current amended complaint is additional false marking claims with respect to US patent no 5,800,832.